- Blonder Tongue Laboratories (BDR -17.2%) reports Q4 EPS of $0.03, but CEO Robert J. Pallé is concerned about 1H'18 outlook and anticipates recovery in 2H.
- Net revenue $5.57M (+2.2% Y/Y) on increased sales of data products offset in part by a decrease in sales of digital video headend products, analogue video headend products and contract manufactured products; Gross profit $2.23M (+26.09% Y/Y); Net earnings $0.26M (+175.74% Y/Y); Cash burn of $300K in 2017.
- The company expects "similar Capex in 2018".
- 10K
- Transcript
Blonder Tongue Laboratories down 17% on 1H outlook
Recommended For You
About BDRL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BDRL | - | - |
Blonder Tongue Laboratories, Inc. |